KARs have been implicated in CNS disorders related to dysfunction of the limbic areas, including mood and anxiety disorders, autism, schizophrenia, as well as epilepsy (Lerma and Marques, 2013; Jane et al., 2009). Here, KARS1 is linked to schizophrenia.